Global Intravenous Solutions Market

Intravenous Solutions Market Size, Share, Growth Analysis, By Product (Total Parenteral Nutrition and Peripheral Parenteral Nutrition), By Nutrients (Carbohydrates, Parenteral Lipid Emulsion), By Region - Industry Forecast 2024-2031

Report ID: SQMIG35E2051 | Region: Global | Published Date: November, 2024
Pages: 192 | Tables: 63 | Figures: 70

Intravenous Solutions Market News

  • In April 2024, Baxter International Inc. pronounced the expansion of its pharmaceuticals product line by launching five injectables in the United States. These introductions reflect Baxter’s commitment to different products that resolve patient needs in major areas like anti-hypotensive and anti-infective medications.
  • In May 2022, Fresenius Kabi completed the acquisition of Ivenix Incorporation, an expert infusion therapy company. The company expanding in MedTech, will offer more advanced infusion therapy offerings. This acquisition is beneficial for capabilities and market offerings as Fresenius Kabi welcomes a unique and committed technology and healthcare team to its family.
  • In March 2022, Otsuka Pharmaceutical Co., Ltd. declared that it received approval for its SAMTASU® 8mg and 16mg Intravenous Infusion for the development and supply. The prodrug, SAMTASU, is used for treating cardiac edema.
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Intravenous Solutions Market size was valued at USD 11.99 Billion in 2022 and is poised to grow from USD 12.95 Billion in 2023 to USD 23.96 Billion by 2031, growing at a CAGR of 8.0% in the forecast period (2024-2031).

The Global Intravenous Solutions Market is a highly competitive global market driven by many international competitors. Prominent corporations with cutting-edge AI and ML technology are Google, IBM, Microsoft, and NVIDIA. To support a wide range of applications across industries, these industry experts concentrate on creating cutting-edge algorithms, scalable platforms, and reliable infrastructure. Rapid advances in technology, strategic alliances, and large expenditures on research and development define the competitive environment. 'Akshar Pharma ', 'Fresenius Kabi AG ', 'MEDEVAC LIFESCIENCES PVT LTD ', 'Pfizer, Inc. ', 'LXIR MEDILABS PVT. LTD ', 'Otsuka Pharmaceutical Co., Ltd. ', 'Baxter ', 'B. Braun ', 'Melsungen AG ', 'Aishwarya Healthcare ', 'Vifor Pharma Management Ltd. ', 'JW Life Science ', 'Amanta Health Care ', 'ICU Medical, Inc. ', 'Grifols S.A. ', 'AptarGroup, Inc. ', 'Sagent Pharmaceuticals, Inc. ', 'Amgen Inc. ', 'Novartis AG'

More patients prefer treatments at home, especially for chronic illnesses, resulting in mounting demand for home IV and infusion therapies. This is significantly fueling the demand for home healthcare. It offers optimal patient comfort and aids compliance, which encourages healthcare professionals to offer more UV solutions for home purposes.

Rise of Home Infusion Therapy: Currently, individuals with chronic diseases are being treated at home due to several benefits like improvements in portable infusion therapies. This trend notably improves patient experience by offering them optimal comfort and reducing hospital admissions. Home infusion treatments are mostly supported by telehealth facilities that enable medical providers to remotely monitor patients, saving time.

Region-wise, North America is the dominating region among others and is expected to lead over the forecast period owing to the region being an innovation center and early adopter of improved infusion technologies. North America is a leading region for several biotechnology and pharmaceutical companies that are heavily investing in research and development of improved IV technologies and solutions. Moreover, the deployment of advanced infusion solutions like smart monitoring systems and pumps improve efficacy and safety of IV therapies. This increases their prominence and importance among healthcare professionals. Regional growth is also impacted by the rising patient population of chronic illness, including cancer, diabetes, cardiovascular diseases, and more, resulting in increased demand of IV therapies. The leading players in the region include Baxter International Inc., B. Braun Medical Inc., McKesson Corporation, Cardinal Health, Inc., Amgen Inc., and more.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Feedback From Our Clients

Global Intravenous Solutions Market

Report ID: SQMIG35E2051

$5,300
BUY NOW GET FREE SAMPLE